874 reports of this reaction
1.6% of all PIROXICAM reports
#2 most reported adverse reaction
RASH is the #2 most commonly reported adverse reaction for PIROXICAM, manufactured by Micro Labs Limited. There are 874 FDA adverse event reports linking PIROXICAM to RASH. This represents approximately 1.6% of all 53,232 adverse event reports for this drug.
Patients taking PIROXICAM who experience rash should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RASH is a less commonly reported adverse event for PIROXICAM, but still significant enough to appear in the safety profile.
In addition to rash, the following adverse reactions have been reported for PIROXICAM:
The following drugs have also been linked to rash in FDA adverse event reports:
RASH has been reported as an adverse event in 874 FDA reports for PIROXICAM. This does not prove causation, but indicates an association observed in post-market surveillance data.
RASH accounts for approximately 1.6% of all adverse event reports for PIROXICAM, making it one of the most commonly reported side effect.
If you experience rash while taking PIROXICAM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.